Galway firm plans to double €3m funding
The funding would secure Crospon’s cashflow position, enabling it to launch its patented Endoflip product on the market
Galway firm Crospon plans to double the e 3 million funding amount it raised last April, in a new funding round planned for this year.
Crospon chief executive John O’Dea said the funding would secure its cashflow position, enabling it to launch its patented Endoflip product on the market.
The company has spent the past year fine-tuning Endoflip, a diagnostic tool for patients with gastroesophageal reflux disease (Gerd), for regulatory approval.
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine